Intermittent prophylactic antibiotics for bronchiectasis-Reference-Cited by-同舟云学术

Intermittent prophylactic antibiotics for bronchiectasis

Published:2022-01-05 Issue:1 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Spencer Sally¹,Donovan Tim²,Chalmers James D³,Mathioudakis Alexander G⁴,McDonnell Melissa J⁵,Tsang Anthony⁶⁷,Leadbetter Peter⁸

Affiliation:

1. Health Research Institute, Faculty of Health, Social Care & Medicine; Edge Hill University; Ormskirk UK

2. Medical Sciences, Institute of Health; University of Cumbria; Lancaster UK

3. University of Dundee, Ninewells Hospital and Medical School; Dundee UK

4. Division of Infection, Immunity and Respiratory Medicine; The University of Manchester, Manchester Academic Health Science Centre; Manchester UK

5. Department of Respiratory Medicine; Galway University Hospital; Galway Ireland

6. Edge Hill University; Ormskirk UK

7. Department of Nursing, Faculty of Health, Social and Psychology; Manchester Metropolitan University; Manchester UK

8. Medical School, Faculty of Health, Social Care and Medicine; Edge Hill University; Ormskirk UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference99 articles.

1. Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): Two randomised double-blind, placebo-controlled phase 3 trials;Barker;Lancet Respiratory Medicine,2014

2. Inhaled antibiotics improve symptoms of cough and sputum in patients with bronchiectasis: a post-hoc analysis of the AIR-BX studies;Crichton;European Respiratory Journal,2020

3. Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies;Crichton;European Respiratory Journal,2020

4. Safety and effectiveness of AZLI (an inhaled antibiotic) in adults with non-cystic fibrosis bronchiectasis (AIR-BX1) clinicaltrials.gov/ct2/show/NCT01313624

5. Airway bacterial load and response to inhaled aztreonam in bronchiectasis;Vidal;American Journal of Respiratory and Critical Care Medicine,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Utility of Metagenomic Next-Generation Sequencing (mNGS) in the Management of Patients With Bronchiectasis: A Single-Center Retrospective Study of 93 Cases;Open Forum Infectious Diseases;2023-08-01

2. Advances in inhaled antibiotics for management of respiratory tract infections;Current Opinion in Pulmonary Medicine;2023-03-03

3. Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms;Current Opinion in Allergy & Clinical Immunology;2022-09-19

4. Monitoring disease progression in childhood bronchiectasis;Frontiers in Pediatrics;2022-09-16

5. Bronchiectasis — A Clinical Review;New England Journal of Medicine;2022-08-11